Altimmune (ALT) Initiated with a Hold at William Blair
Altimmune (ALT – Research Report) received a Hold rating and price target from William Blair analyst Andy Hsieh today. The company’s shares ...
William Blair Initiates a Hold Rating on Terns Pharmaceuticals (TERN)
Terns Pharmaceuticals (TERN – Research Report) received a Hold rating and price target from William Blair analyst Andy Hsieh today. The ...
The Manila Times2h
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
(Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal ...
Healio2h
Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial
The AHFIRM trial did not demonstrate a beneficial effect of larsucosterol on 90-day mortality or the need for liver transplant among patients with severe alcohol-associated hepatitis, or AH, according ...